• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过人乙醚 - 去极化激活的钾离子通道(hERG通道)的铷离子通量会影响通道阻断药物的效力:与使用高通量铷离子外流测定法获得的数据的相关性。

Rb+ flux through hERG channels affects the potency of channel blocking drugs: correlation with data obtained using a high-throughput Rb+ efflux assay.

作者信息

Rezazadeh Saman, Hesketh J Christian, Fedida David

机构信息

Department of Physiology, University of British Columbia, Vancouver, BC, Canada.

出版信息

J Biomol Screen. 2004 Oct;9(7):588-97. doi: 10.1177/1087057104264798.

DOI:10.1177/1087057104264798
PMID:15475478
Abstract

The nonradioactive Rb+ efflux assay has become a reliable and efficient high-throughput hERG screening method, but it is limited by its low sensitivity for potent hERG blockers. Using the patch clamp technique, the authors found that the low sensitivity is due in part to the use of Rb+ as the permeating cation in the assay. The affinities of the drugs measured by patch clamp technique in the presence of Rb+ were 3- to 10-fold lower than when measured by the same method in the presence of K+ ions. The apparent affinity of the drugs decreased even further when monitored by the Rb+ efflux assay. It was also observed that Rb+ had minimal effects on the activation properties of channels while there was a significant change in the half-inactivation potential. This voltage shift reduces hERG channel inactivation at efflux assay potentials, and will reduce the affinity of hERG-blocking drugs that bind to inactivated states of the channel. In combination with the effects of elevated extracellular ion concentrations, it is likely that Rb+ modulation of hERG channel inactivation is largely responsible for the reduced drug potencies observed in the Rb+ efflux assay.

摘要

非放射性铷离子(Rb⁺)外流测定法已成为一种可靠且高效的高通量人乙醚相关基因(hERG)筛选方法,但它对强效hERG阻滞剂的低敏感性限制了其应用。通过膜片钳技术,作者发现这种低敏感性部分归因于在该测定法中使用Rb⁺作为通透阳离子。在存在Rb⁺的情况下,通过膜片钳技术测得的药物亲和力比在存在钾离子(K⁺)的情况下用相同方法测得的低3至10倍。当通过Rb⁺外流测定法监测时,药物的表观亲和力甚至进一步降低。还观察到,Rb⁺对通道的激活特性影响极小,而半失活电位有显著变化。这种电压偏移降低了在外流测定电位下hERG通道的失活,并且会降低与通道失活状态结合的hERG阻断药物的亲和力。结合细胞外离子浓度升高的影响,Rb⁺对hERG通道失活的调节很可能是导致在Rb⁺外流测定法中观察到药物效力降低的主要原因。

相似文献

1
Rb+ flux through hERG channels affects the potency of channel blocking drugs: correlation with data obtained using a high-throughput Rb+ efflux assay.通过人乙醚 - 去极化激活的钾离子通道(hERG通道)的铷离子通量会影响通道阻断药物的效力:与使用高通量铷离子外流测定法获得的数据的相关性。
J Biomol Screen. 2004 Oct;9(7):588-97. doi: 10.1177/1087057104264798.
2
Characterization of a hERG screen using the IonWorks HT: comparison to a hERG rubidium efflux screen.使用IonWorks HT进行的hERG筛选的特性:与hERG铷外流筛选的比较。
Assay Drug Dev Technol. 2005 Feb;3(1):47-57. doi: 10.1089/adt.2005.3.47.
3
Optimisation and validation of a medium-throughput electrophysiology-based hERG assay using IonWorks HT.使用IonWorks HT对基于中通量电生理学的hERG检测方法进行优化与验证。
J Pharmacol Toxicol Methods. 2006 Sep-Oct;54(2):189-99. doi: 10.1016/j.vascn.2006.02.003. Epub 2006 Mar 6.
4
Evaluation of the rubidium efflux assay for preclinical identification of HERG blockade.用于临床前鉴定HERG阻断的铷外流试验评估
Assay Drug Dev Technol. 2006 Feb;4(1):73-82. doi: 10.1089/adt.2006.4.73.
5
Validation of an atomic absorption rubidium ion efflux assay for KCNQ/M-channels using the ion Channel Reader 8000.使用离子通道读数器8000对用于KCNQ/M通道的原子吸收铷离子外流测定法进行验证。
Assay Drug Dev Technol. 2004 Oct;2(5):525-34. doi: 10.1089/adt.2004.2.525.
6
Development and evaluation of high throughput functional assay methods for HERG potassium channel.
J Biomol Screen. 2001 Oct;6(5):325-31. doi: 10.1177/108705710100600506.
7
The [3H]dofetilide binding assay is a predictive screening tool for hERG blockade and proarrhythmia: Comparison of intact cell and membrane preparations and effects of altering [K+]o.[3H]多非利特结合试验是一种用于预测hERG阻断和致心律失常作用的筛选工具:完整细胞与膜制剂的比较以及改变细胞外钾离子浓度([K+]o)的影响。
J Pharmacol Toxicol Methods. 2004 Nov-Dec;50(3):187-99. doi: 10.1016/j.vascn.2004.04.001.
8
High-affinity blockade of human ether-a-go-go-related gene human cardiac potassium channels by the novel antiarrhythmic drug BRL-32872.新型抗心律失常药物BRL-32872对人醚-去极化相关基因人心脏钾通道的高亲和力阻断作用。
J Pharmacol Exp Ther. 2001 May;297(2):753-61.
9
Inhibition of cardiac HERG currents by the DNA topoisomerase II inhibitor amsacrine: mode of action.DNA拓扑异构酶II抑制剂安吖啶对心脏HERG电流的抑制作用:作用模式
Br J Pharmacol. 2004 Jun;142(3):485-94. doi: 10.1038/sj.bjp.0705795. Epub 2004 May 17.
10
Intracellular K+ is required for the inactivation-induced high-affinity binding of cisapride to HERG channels.细胞内钾离子是西沙必利与HERG通道失活诱导的高亲和力结合所必需的。
Mol Pharmacol. 2005 Sep;68(3):855-65. doi: 10.1124/mol.105.012278. Epub 2005 Jun 20.

引用本文的文献

1
High throughput clone screening on overexpressed hERG1 and Kv1.3 potassium channels using ion channel reader (ICR) label free technology.使用离子通道读数器(ICR)无标记技术对过表达的人乙醚相关基因1(hERG1)和钾通道蛋白1.3(Kv1.3)钾通道进行高通量克隆筛选。
Heliyon. 2023 Sep 19;9(10):e20112. doi: 10.1016/j.heliyon.2023.e20112. eCollection 2023 Oct.
2
High-Throughput Chemical Screening and Structure-Based Models to Predict hERG Inhibition.用于预测hERG抑制的高通量化学筛选和基于结构的模型
Biology (Basel). 2022 Jan 28;11(2):209. doi: 10.3390/biology11020209.
3
Cardiac hERG K Channel as Safety and Pharmacological Target.
心脏 hERG K 通道作为安全性和药理学靶点。
Handb Exp Pharmacol. 2021;267:139-166. doi: 10.1007/164_2021_455.
4
Risk Assessment in Acquired Long QT Syndrome: The Devil Is in the Details.获得性长QT综合征的风险评估:细节决定成败。
Front Physiol. 2017 Nov 16;8:934. doi: 10.3389/fphys.2017.00934. eCollection 2017.
5
Investigation of miscellaneous hERG inhibition in large diverse compound collection using automated patch-clamp assay.使用自动膜片钳测定法对大量不同化合物库中的杂项人乙醚相关基因(hERG)抑制作用进行研究。
Acta Pharmacol Sin. 2016 Jan;37(1):111-23. doi: 10.1038/aps.2015.143.
6
A highly selective mitochondria-targeting fluorescent K(+) sensor.一种高度选择性的线粒体靶向荧光钾离子传感器。
Angew Chem Int Ed Engl. 2015 Oct 5;54(41):12053-7. doi: 10.1002/anie.201506038. Epub 2015 Aug 21.
7
Profiling diverse compounds by flux- and electrophysiology-based primary screens for inhibition of human Ether-à-go-go related gene potassium channels.通过基于通量和电生理学的初步筛选对多种化合物进行分析,以检测其对人醚-去-去相关基因钾通道的抑制作用。
Assay Drug Dev Technol. 2010 Dec;8(6):743-54. doi: 10.1089/adt.2010.0339.
8
Minimizing repolarization-related proarrhythmic risk in drug development and clinical practice.最小化药物研发和临床实践中与复极相关的致心律失常风险。
Drugs. 2010 Mar 26;70(5):573-603. doi: 10.2165/11535230-000000000-00000.
9
An introduction to QT interval prolongation and non-clinical approaches to assessing and reducing risk.QT 间期延长简介及评估和降低风险的非临床方法。
Br J Pharmacol. 2010 Jan;159(1):12-21. doi: 10.1111/j.1476-5381.2009.00207.x.
10
A new homogeneous high-throughput screening assay for profiling compound activity on the human ether-a-go-go-related gene channel.一种用于分析化合物对人类醚 - 去极化相关基因通道活性的新型均相高通量筛选测定法。
Anal Biochem. 2009 Nov 1;394(1):30-8. doi: 10.1016/j.ab.2009.07.003. Epub 2009 Jul 5.